Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Prepaid Assets (2016 - 2025)

Guided Therapeutics' Prepaid Assets history spans 16 years, with the latest figure at $90000.0 for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 47.98% to $90000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $90000.0, a 47.98% decrease, with the full-year FY2025 number at $90000.0, down 47.98% from a year prior.
  • Prepaid Assets hit $90000.0 in Q4 2025 for Guided Therapeutics, down from $123000.0 in the prior quarter.
  • Over the last five years, Prepaid Assets for GTHP hit a ceiling of $453000.0 in Q1 2022 and a floor of $23000.0 in Q2 2025.
  • Historically, Prepaid Assets has averaged $149200.0 across 5 years, with a median of $130000.0 in 2022.
  • Biggest five-year swings in Prepaid Assets: surged 1061.54% in 2022 and later plummeted 79.46% in 2025.
  • Tracing GTHP's Prepaid Assets over 5 years: stood at $377000.0 in 2021, then plummeted by 63.66% to $137000.0 in 2022, then grew by 18.98% to $163000.0 in 2023, then grew by 6.13% to $173000.0 in 2024, then tumbled by 47.98% to $90000.0 in 2025.
  • Business Quant data shows Prepaid Assets for GTHP at $90000.0 in Q4 2025, $123000.0 in Q3 2025, and $23000.0 in Q2 2025.